Database

Startups

Main Industry
Health Care
Main Product/Service
1. LBS-008
2. LBS-007
3. LBS-002
4. LBS-009
Founded Year
2016
Unified Business No.
43814765
Status
Active
Number of Employees
0
Total Paid-in Capital
827,250,000 (NT$)
Location of Company
Taiwan , Taipei City
Exit Status
Emerging Stock Exchange(2018)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Introduction
Lin BioScience, Inc. (TPEx: 6696) is a drug development company established in 2016 focusing on advancing novel therapies and first-in-class treatments for unmet medical needs in various therapeutic areas such as ophthalmology, oncology, and metabolic dis



More2 ↓

Similar Companies

TAIWAN BIO THERAPEUTICS INC.

Leveraging the FAST CGT platform to enhance the specificity, persistence, and stability of regulatory T cells, improving their ability to restore immune tolerance and suppress inflammation as a targeted alternative to non-selective, high-risk immunosuppre

Acura NanoMedicine Corporation

1. Out-licensing of innovative drug products, including the AN-8 series, a novel therapy designed to reverse cancer drug resistance, and other pharmaceuticals.
2. Utilizing proprietary technology platforms — (1) the HTPVAC drug development platform and (2

Neo-Pharma Biotech Co., Ltd.

Edge AI Solutions
AI Inference Device
DeviceEdge Jetson Series
DeviceEdge AI on ARM Series
AI Inference / Training System
MegaEdge PCIe Series
MegaEdge M.2 Series
MegaEdge MXM Series
AI Inference / Training Server
AI Accelerator & GPU
CoreEdge PCIe Card
I
:::